Vascular contractile potency of endothelin-1 is increased in the presence of monocytes or macrophages.
Accumulation of inflammatory cells and altered responsiveness to vasoactive mediators are commonly observed events in atherosclerotic vessels. We studied the effect of monocytic cells on endothelin-1 (ET-1)-induced contraction of strips of guinea pig carotid artery. The vascular contractile potency of ET-1 was increased markedly in the presence of human peripheral blood monocytes, guinea pig alveolar macrophages (M phi), and the human monocytic cell line, THP-1. Specific binding of 125I-labeled ET-1 to these cells was detected, and Scatchard analysis indicated a dissociation constant value of approximately 1 nM. In contrast, the human monocytic cell line, U-937, failed to bind 125I-ET-1 and did not alter ET-1 potency, suggesting that the ability of monocytic cells to increase ET-1 potency requires expression of ET receptors. Selective inhibition of ET-1 binding to vascular smooth muscle with BQ-123, an ETA receptor antagonist that does not inhibit ET-1 binding to monocytes, resulted in complete inhibition of vascular contraction. These data indicate that ET-1-induced vasoconstriction may be increased by monocytic cells via stimulation of monocyte endothelin receptors.
Magazine
H I
HI
Department of Biology, Queens College, City University of New York, Flushing 11367.
Andersen
T T
TT
Bruner
C A
CA
Malik
A B
AB
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D002339:Carotid Arteries / Q000187:drug effects; D002460:Cell Line; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005260:Female; D005404:Fixatives / Q000494:pharmacology; D005557:Formaldehyde / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D008264:Macrophages / Q000502:physiology*; D008297:Male; D009000:Monocytes / Q000378:metabolism / Q000502:physiology*; D010456:Peptides, Cyclic / Q000494:pharmacology; D011108:Polymers / Q000494:pharmacology; D017382:Reactive Oxygen Species / Q000494:pharmacology; D017466:Receptors, Endothelin / Q000378:metabolism; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D005404:Fixatives; D010456:Peptides, Cyclic; D011108:Polymers; D017382:Reactive Oxygen Species; D017466:Receptors, Endothelin; D014662:Vasoconstrictor Agents; D005557:Formaldehyde; D016718:Arachidonic Acid; C072247:cyclo(Trp-Asp-Pro-Val-Leu); C003043:paraform